Literature DB >> 31364141

Effects of propofol on myocardial ischemia reperfusion injury through inhibiting the JAK/STAT pathway.

W-Y Zhang1, Q-L Zhang, M-J Xu.   

Abstract

OBJECTIVE: The aim of this study was to investigate the effect of propofol (PPF) on myocardial ischemia-reperfusion injury (MIRI) by inhibiting the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, and to explore the possible underlying mechanism.
MATERIALS AND METHODS: A total of 60 Sprague-Dawley (SD) rats were randomly divided into 5 groups, including the Sham group (n=12), the MIRI model group (n=12), the PPF pretreatment group (n=12), the RG81640-CH (RG) pretreatment group (n=12) and the PPF+RG pretreatment group (n=12). The hemodynamic parameters of rats in each group were measured. Serum samples were collected from rats in each group. Meanwhile, the levels of lactate dehydrogenase (LDH), creatine kinase-muscle/brain (CK-MB), nicotinamide adenine dinucleotide+ (NAD+) and inflammatory factors, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemotactic protein (MCP), were detected by enzyme-linked immunosorbent assay (ELISA). Myocardial infarction area of rats in each group was detected via 2,3,5-triphenyl tetrazolium chloride (TTC) staining. Moreover, the JAK/STAT pathway, as well as apoptosis indexes in myocardial cells of rats, were detected via Western blotting.
RESULTS: Compared with the Sham group, the contents of LDH, CK-MB, NAD+ and inflammatory factors, as well as the area of myocardial infarction were significantly increased in the MIRI group (p<0.05). In terms of hemodynamic parameters, the left ventricular end-diastolic pressure (LVEDP) was significantly increased in the MIRI group. However, heart rate (HR), left ventricular developed pressure (LVDP) and maximal rate of the increase/decrease of left ventricular pressure (±dp/dtmax) were significantly decreased in the MIRI group when compared with those of the Sham group (p<0.05). Compared with the MIRI group, the contents of LDH, CK-MB, NAD+ and inflammatory factors, as well as the area of myocardial infarction and LVEDP were significantly declined in the PPF group. Meanwhile, HR, LVDP and ±dp/dtmax were remarkably increased (p<0.05). No significant differences in each index were found between the PPF + RG group and the MIRI group (p>0.05). Western blotting revealed that the protein level of B-cell lymphoma-2 (Bcl-2) was remarkably increased, while the activity of Caspase-3 was decreased in the PPF group when compared with the MIRI group (p<0.05). In addition, the protein expression levels of JAK1, STAT1 and STAT3 in the PPF group were significantly decreased than those of the MIRI group (p<0.05). However, completely opposite trends were found in the RG group.
CONCLUSIONS: PPF reduces the release of inflammatory factors and alleviates tissue damage caused by myocardial apoptosis in MIRI rats by inhibiting the activation of the JAK/STAT pathway. Our findings indicate that PPF has a certain myocardial protective effect on MIRI.

Entities:  

Year:  2019        PMID: 31364141     DOI: 10.26355/eurrev_201907_18457

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway.

Authors:  Shengqiang Li; Zhen Lei; Meng Zhao; Yonghao Hou; Di Wang; Xingli Xu; Xiaowen Lin; Jingxin Li; Shuhai Tang; Jingui Yu; Tao Meng
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.

Authors:  Ming Xu; XiaoYong Li; Laichun Song
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

3.  microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis.

Authors:  Yong Li; Hongbo Zhang; Zhanhu Li; Xiaoju Yan; Yuan Li; Shuai Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-03-03       Impact factor: 2.298

Review 4.  Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?

Authors:  Cong Chen; Lin-Tong Yu; Bai-Ru Cheng; Jiang-Lin Xu; Yun Cai; Jia-Lin Jin; Ru-Li Feng; Long Xie; Xin-Yan Qu; Dong Li; Jing Liu; Yan Li; Xiao-Yun Cui; Jin-Jin Lu; Kun Zhou; Qian Lin; Jie Wan
Journal:  Front Cardiovasc Med       Date:  2022-02-17

Review 5.  Targeting NAD+: is it a common strategy to delay heart aging?

Authors:  Bing Liang; Xin-Lin Liu; Yang Yuan; Wen-Jing Liu; Bing-Huan Huang; Shan-Bo Yang; Yuan-Zhen Gao; Jing-Sen Meng; Meng-Jiao Li; Ting Ye; Chuan-Zhi Wang; Xiao-Kun Hu; Dong-Ming Xing
Journal:  Cell Death Discov       Date:  2022-04-26

6.  Comparing the impact on the prognosis of acute myocardial infarction critical patients of using midazolam, propofol, and dexmedetomidine for sedation.

Authors:  Xiaowei Jiang; Min Yan
Journal:  BMC Cardiovasc Disord       Date:  2021-12-07       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.